Daniel Y. Lee, MD, PhD

Medicine & Life Sciences

1. Antibodies 16%
2. Antigens 19%
3. Chimeric Antigen Receptors 16%
4. Copper-64 37%
5. CY5.5 cyanine dye 22%
6. Cytotoxic T-Lymphocytes 22%
7. DNA 14%
8. DNA Primers 27%
9. DNA Replication 26%
10. Electrons 16%
11. Epigenomics 18%
12. Evaluation Studies 18%
13. Genomics 24%
14. Gold 42%
15. Hodgkin Disease 24%
16. Human Herpesvirus 4 56%
17. Inhibitory Concentration 50 18%
18. Integrins 39%
19. Lymphoma 55%
20. Magnetic Resonance Imaging 13%
21. Membrane Proteins 25%
22. Mitochondria 17%
23. Mitochondrial DNA 65%
24. Mitochondrial RNA 35%
25. Modern 1601-history 12%
26. Molecular Imaging 38%
27. Multicenter Studies 18%
28. N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine 16%
29. Nanoparticles 57%
30. Neoplasm Antigens 19%
31. Neoplasms 60%
32. Pharmaceutical Preparations 12%
33. Positron Emission Tomography Computed Tomography 22%
34. Positron-Emission Tomography 19%
35. Precursor Cell Lymphoblastic Leukemia-Lymphoma 20%
36. Protein-Tyrosine Kinases 18%
37. R-Loop Structures 100%
38. Radiopharmaceuticals 24%
39. Replication Origin 51%
40. Ribonucleases 46%
41. RNA 21%
42. RNA primers 38%
43. Systemic Inflammatory Response Syndrome 25%
44. Systems Analysis 23%
45. T-Lymphocytes 67%
46. Theranostic Nanomedicine 36%
47. Therapeutics 17%
48. Transforming Growth Factors 14%
49. Tumor Escape 27%
50. Vascular Endothelial Growth Factor Receptor 24%